The metabolic syndrome (MetSyn) is a constellation of metabolic abnormalities and is associated with increased risk of developing diabetes ([@B1]), cardiovascular disease ([@B2]), and higher mortality from all causes ([@B3]). Among the few studies using nationally representative samples on MetSyn ([@B4][@B5][@B6][@B7][@B8]--[@B9]), Ford et al. ([@B9]) estimated an increasing trend of MetSyn prevalence by comparing the Third National Health and Nutrition Examination Survey (NHANES III) and NHANES 1999--2000 data. However, because of the smaller sample size of NHANES 1999--2000, the change in MetSyn prevalence for various subpopulations, which is necessary to track age and ethnicity specific trends, was not estimated. Therefore, the objective of this study is to compare the prevalence of MetSyn between NHANES III and NHANES 1999--2006 among U.S. adults of different races or ethnicities.

RESEARCH DESIGN AND METHODS
===========================

We identified the cases of MetSyn using the revised American Heart Association/National Cholesterol Education Program Adult Treatment Panel III definition ([@B10]), including medication uses for appropriate MetSyn criteria. Data for this study were obtained from public-use datasets of the NHANES III, NHANES 1988--1994 (data release 11\#1A), and four continuous NHANES data releases: 1999--2000, 2001--2002, 2003--2004, and 2005--2006. Details of survey and laboratory procedure of NHANES are published elsewhere ([@B11][@B12]--[@B13]). Data from NHANES 1999--2006 were combined for this study to produce estimates of MetSyn for demographic subpopulations (e.g., sex-age-race/ethnicity) with greater statistical reliability. Because the data on fasting triglycerides and fasting glucose were required to identify MetSyn and those measurements were done on a subsample population, the sample weights for the subsample were used in this study.

The appropriate sample weights for combined NHANES 1999--2006 were constructed using National Center for Health Statistics guidelines ([@B14]). To maintain the consistency of blood pressure data between the two surveys, the procedure described by Ford et al. ([@B9]) was followed.

The continuous NHANES measured fasting glucose and serum triglycerides from blood samples drawn in the morning; therefore, only participants who attended a morning examination session for NHANES III were included in this analysis. Otherwise, the sample includes men and nonpregnant women aged ≥20 years who fasted for at least 8 h. The number of participants in the final analysis was 6,423 for NHANES III and 6,962 for NHANES 1999--2006. Statistical analyses to calculate prevalence were performed using the survey procedures in SAS software version 9.1 (SAS Institute, Cary, NC). The statistical significance of the change in MetSyn prevalence between the two surveys was examined by Student *t* test, in which the square root of the sum of the squared standard errors was utilized to calculate the pooled standard error of the difference in the mean.

RESULTS
=======

The age-adjusted prevalence of four of the five metabolic abnormalities of MetSyn increased significantly between the surveys for women: abdominal obesity 46.0 ± 1.4% to 58.0 ± 1.1%, *P* \< 0.001; hypertriglyceridemia 24.7 ± 1.2% to 27.6 ± 0.8%, *P* = 0.042; high blood pressure (HBP) 27.8 ± 0.9% to 36.6 ± 0.8%, *P* \< 0.001; high fasting glucose 24.2 ± 1.2% to 29.2 ± 1.0%, *P* = 0.002. However, for men, age-adjusted prevalence significantly increased in abdominal obesity (30.4 ± 1.6% to 41.1 ± 1.1%, *P* \< 0.001) and HBP (32.0 ± 0.8% to 40.0 ± 0.7%, *P* \< 0.001) only. The age-adjusted prevalence of low HDL cholesterol significantly decreased in both sexes (men: 36.4 ± 1.7% to 27.6 ± 1.0%, *P* \< 0.001; women: 39.6 ± 1.4% to 33.8 ± 1.1%, *P* = 0.001) between the surveys.

Both age-adjusted and age-specific prevalence of MetSyn for NHANES 1999--2006 were significantly higher than for NHANES III ([Table 1](#T1){ref-type="table"}). The unadjusted (*P* = 0.012) and age-adjusted (*P* = 0.046) prevalence increased significantly between the two surveys for men; however, there was no significant change in any of the three age-groups. For women, both unadjusted and age-adjusted (*P* \< 0.001) prevalence increased significantly between the two surveys, with a significant increase noted in all three age-groups. Among non-Hispanic White (NHW) subjects, both men and women showed significant increases in unadjusted (men: *P* = 0.010; women: *P* = 0.001) and age-adjusted (men: *P* = 0.048; women: *P* = 0.007) prevalence of MetSyn. However, when classified by age-groups, only women aged 20--39 years showed significant increase (*P* = 0.010). Prevalence of MetSyn did not change significantly among non-Hispanic Black (NHB) men (*P* \> 0.050) between the two surveys, but NHB women aged 20--39 years showed a significant increase in prevalence (*P* = 0.036). The age-adjusted prevalence of MetSyn in NHANES 1999--2006 was highest among Mexican Americans (men: 36.6 ± 1.9%; women: 42.6 ± 1.7%) with little change in this group from NHANES III. Using the unadjusted prevalence rates from combined sample population of NHANES 1999--2006, we estimated that about 32.4 million men and 35.3 million women in U.S. had MetSyn. Among U.S. adults with MetSyn, ∼50.6 million were NHW, ∼6.3 million were NHB, and ∼4.6 million were Mexican Americans.

###### 

Age-specific (unadjusted) and age-adjusted (adjusted) prevalence of the metabolic syndrome among U.S. adults aged ≥20 years in the NHANES III and NHANES 1999--2006

                              NHANES III   NHANES 1999--2006   Absolute change %   Relative change %   *P*                             
  --------------------------- ------------ ------------------- ------------------- ------------------- ------ -------- ------- ------- ---------
  Total                                                                                                                                
          Unadjusted          6,423        27.9                (1.1)               6,962               34.1   (0.8)    6.3     22.6    \<0.001
          Adjusted            6,423        29.2                (1.0)               6,962               34.2   (0.7)    5.0     17.0    \<0.001
      Men                                                                                                                              
          Unadjusted          3,059        29.3                (1.6)               3,582               34.2   (1.1)    4.9     16.8    0.012
          Adjusted            3,059        31.4                (1.4)               3,582               34.9   (1.0)    3.5     11.2    0.046
          Aged 20--39 years   1,217        15.7                (2.1)               1,229               20.2   (1.4)    4.4     28.1    0.080
          Aged 40--59 years   839          36.3                (2.3)               1,114               41.2   (1.7)    5.0     13.7    0.083
          Aged 60+ years      1,003        50.3                (2.3)               1,239               49.9   (2.0)    −0.4    −0.8    0.899
      Women                                                                                                                            
          Unadjusted          3,364        26.5                (1.4)               3,380               34.1   (1.10)   7.5     28.4    \<0.001
          Adjusted            3,364        27.1                (1.2)               3,380               33.3   (1.0)    6.2     22.8    \<0.001
          Aged 20--39 years   1,447        10.7                (1.7)               1,061               16.7   (1.2)    6.0     55.5    0.003
          Aged 40--59 years   943          30.2                (2.3)               1,113               36.3   (1.7)    6.2     20.4    0.033
          Aged 60+ years      974          50.2                (2.2)               1,206               56.8   (1.9)    6.6     13.1    0.022
  NHW                                                                                                                                  
      Men                                                                                                                              
          Unadjusted          1,284        30.8                (2.0)               1,881               37.0   (1.3)    6.3     20.3    0.010
          Adjusted            1,284        32.1                (1.9)               1,881               36.5   (1.2)    4.4     13.8    0.048
          Aged 20--39 years   337          16.6                (2.8)               523                 22.3   (2.0)    5.8     35.0    0.090
          Aged 40--59 years   361          37.1                (3.0)               618                 42.2   (2.0)    5.1     13.7    0.164
          Aged 60+ years      586          50.4                (2.5)               740                 51.4   (2.4)    1.0     2.1     0.762
      Women                                                                                                                            
          Unadjusted          1,462        26.5                (1.6)               1,725               33.3   (1.4)    6.8     25.6    0.001
          Adjusted            1,462        26.2                (1.4)               1,725               31.4   (1.3)    5.2     20.0    0.007
          Aged 20--39 years   446          9.1                 (1.9)               483                 16.0   (1.8)    6.8     74.5    0.010
          Aged 40--59 years   411          29.4                (2.7)               543                 33.0   (2.2)    3.7     12.6    0.292
          Aged 60+ years      605          50.2                (2.5)               699                 55.2   (2.1)    5.0     9.9     0.121
  NHB                                                                                                                                  
      Men                                                                                                                              
          Unadjusted          762          20.2                (1.2)               634                 22.0   (1.6)    1.8     8.8     0.372
          Adjusted            762          23.1                (1.4)               634                 24.9   (1.6)    1.9     8.0     0.388
          Aged 20--39 years   375          13.9                (1.5)               261                 11.9   (2.0)    −2.0    −14.1   0.439
          Aged 40--59 years   210          24.3                (3.10)              192                 26.6   (3.2)    2.3     9.3     0.613
          Aged 60+ years      177          36.9                (3.3)               181                 44.6   (3.3)    7.7     21.0    0.098
      Women                                                                                                                            
          Unadjusted          913          26.4                (1.7)               656                 34.3   (1.7)    7.9     30.0    0.001
          Adjusted            913          30.6                (1.7)               656                 36.5   (1.6)    5.9     19.3    0.014
          Aged 20--39 years   472          12.6                (1.6)               244                 18.9   (2.5)    6.3     49.8    0.036
          Aged 40--59 years   268          35.6                (2.7)               230                 40.7   (3.4)    5.1     14.2    0.241
          Aged 60+ years      173          53.3                (4.0)               182                 59.9   (2.7)    6.6     12.3    0.180
  Mexican American                                                                                                                     
      Men                                                                                                                              
          Unadjusted          893          28.5                (2.2)               810                 29.4   (2.2)    0.9     3.3     0.767
          Adjusted            893          37.8                (2.1)               810                 36.6   (1.9)    −1.2    −3.1    0.671
          Aged 20--39 years   457          17.6                (2.7)               324                 18.9   (2.8)    1.3     7.3     0.743
          Aged 40--59 years   226          48.0                (3.5)               228                 44.4   (3.0)    −3.6    −7.5    0.433
          Aged 60+ years      210          56.1                (5.4)               258                 54.5   (3.6)    −1.6    −2.8    0.810
      Women                                                                                                                            
          Unadjusted          853          33.1                (1.6)               741                 36.4   (2.2)    3.3     10.0    0.222
          Adjusted            853          41.7                (1.7)               741                 42.6   (1.7)    0.9     2.2     0.701
          Aged 20--39 years   475          19.8                (1.9)               241                 20.9   (2.9)    1.1     5.3     0.758
          Aged 40--59 years   217          51.4                (3.2)               244                 49.6   (3.3)    −1.8    −3.5    0.699
          Aged 60+ years      161          63.6                (3.8)               256                 68.6   (3.9)    5.1     8.0     0.352
  Other                                                                                                                                
      Men                                                                                                                              
          Unadjusted          120          25.8                (4.7)               257                 28.9   (3.3)    3.1     12.0    0.590
          Adjusted            120          30.5                (4.3)               257                 31.9   (3.2)    1.4     4.5     0.798
          Aged 20--39 years   48           9.1                 (5.3)               121                 17.5   (3.2)    8.4     92.8    0.177
          Aged 40--59 years   42           33.5                (0.8)               76                  46.5   (7.1)    13.0    38.9    0.316
          Aged 60+ years      30           62.3                (0.5)               60                  33.0   (4.8)    −29.3   −47.1   0.012
      Women                                                                                                                            
          Unadjusted          136          22.7                (4.6)               258                 37.9   (4.2)    15.2    67.1    0.015
          Adjusted            136          24.0                (3.9)               258                 39.3   (3.8)    15.3    63.6    0.005
          Aged 20--39 years   54           15.6                (7.5)               93                  14.8   (4.6)    −0.8    −4.9    0.931
          Aged 40--59 years   47           21.7                (8.3)               96                  48.8   (4.6)    27.1    124.4   0.005
          Aged 60+ years      35           42.2                (7.7)               69                  66.1   (6.8)    23.9    56.6    0.021

The age-adjusted prevalence of U.S. adults reporting diabetes (other than pregnancy related) or having a fasting blood glucose ≥126 mg/dl significantly increased in both sexes (men: 8.1 ± 0.6% to 10.5 ± 0.6%, *P* = 0.005; women: 5.8 ± 0.6% to 8.5 ± 0.5%, *P* = 0.001) between the two surveys. The age-adjusted prevalence of MetSyn among U.S. men without diabetes did not change significantly (27.6 ± 1.4% to 30.6 ± 1.1%, *P* = 0.08); however, the prevalence significantly increased for women without diabetes (24.0 ± 1.2% to 29.4 ± 1.0%, *P* = 0.001), including women aged 20--39 years (10.0 ± 1.6% to 15.8 ± 1.2%, *P* = 0.003) and aged 40--59 years (25.8 ± 2.4% to 31.6 ± 1.7%, *P* = 0.049).

CONCLUSIONS
===========

Ford et al. ([@B9]) estimated that ∼50 million U.S. adults in 1990 and ∼64 million in 2000 had MetSyn, representing a 28% increase in prevalence. From the combined NHANES 1999--2006 data, we estimated ∼68 million U.S. adults had MetSyn, or a further increase of 6%. The prevalence of MetSyn in U.S. adults in 1999--2006 was 34.1 ± 0.8% (after age adjustment 34.2 ± 0.7%), which is a significant increase from 1988--1994, and more so in women (28.4%) than in men (16.8%). Further, in both NHW and NHB the prevalence of MetSyn significantly increased in women, particularly younger women (aged 20--39 years). The increased prevalence of MetSyn was primarily due to increases in abdominal obesity and HBP.

An increase in MetSyn prevalence is expected to be followed by an increase in diabetes prevalence, though of a lesser magnitude. Between the two surveys, there was a 4.3% increase in age-adjusted prevalence of MetSyn among adults without diabetes and a 2.6% increase in diabetes. As we continue to see an increase in MetSyn, especially in certain ethnic groups and younger women, we will see a concomitant increase in diabetes and its comorbidities and associated medical costs.
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